Centre de recherche et le développement des médicaments ### 📋 Eligible Entities - Pharmaceutical and biotech companies (all sizes) - Research institutions and universities - Contract research organizations (CROs) - Medical device manufacturers - Small and medium-sized enterprises (SMEs) in life sciences - Joint ventures between industry and academic partners - Non-profit research organizations focused on drug development ### 💰 Funding Details - Grant Type: Access-based funding (non-repayable support) - Funding Structure: In-kind contributions and facility access rather than direct cash grants - Cost-Sharing: Typically requires participant cost-sharing or matching contributions - Repayability: Non-repayable (grant-based, not loan-based) - Specific Amount: Not specified in program description; varies by project scope and facility utilization ### 🛠️ Approved Expenses - Research and development activities in pharmaceuticals and drug development - Access to scientific research facilities and laboratories in Vancouver - Collaborative research projects with university partners - Industry-academic partnership initiatives - Commercial expertise and business development support - Technology transfer and commercialization support - Scientist and researcher salaries (within collaborative projects) - Equipment usage and laboratory testing costs ### ⚠️ Conditions & Milestones - Location Requirement: Research activities must utilize facilities in Vancouver - Collaboration Mandate: Projects should involve partnerships with industry, academia, or both - Knowledge Sharing: Participants must engage in collaborative knowledge exchange - Reporting: Regular progress reports and milestones documentation likely required - Intellectual Property: Terms regarding ownership and rights to research outcomes must be negotiated - Timeline: Project-specific milestones and completion targets to be established with program administrators - Facility Access: Approved use of Vancouver-based research infrastructure with defined access protocols